Annual Financials for Procter & Gamble Co.
Fiscal year is July-June. All values USD millions. |
2018 | 2019 | 2020 | 2021 | 2022 |
5-year trend |
Sales/Revenue
|
66.83B | 67.68B | 70.95B | 76.12B | 80.19B | |
Sales Growth |
- | 1.27% | 4.83% | 7.28% | 5.35% | |
Cost of Goods Sold (COGS) incl. D&A |
33.61B | 34.25B | 34.64B | 36.97B | 41.98B | |
COGS excluding D&A |
30.78B | 31.42B | 31.62B | 34.24B | 39.17B | |
Depreciation & Amortization Expense |
2.83B | 2.82B | 3.01B | 2.74B | 2.81B | |
Depreciation |
2.53B | 2.48B | 2.65B | 2.42B | 2.5B | |
Amortization of Intangibles |
302M | 349M | 360M | 318M | 312M | |
COGS Growth |
- | 1.89% | 1.14% | 6.75% | 13.53% | |
Gross Income |
33.22B | 33.44B | 36.31B | 39.14B | 38.21B | |
Gross Income Growth |
- | 0.66% | 8.60% | 7.79% | -2.38% | |
Gross Profit Margin |
- | - | - | - | 47.65% | NA |
|
2018 | 2019 | 2020 | 2021 | 2022 |
5-year trend |
SG&A Expense |
18.8B | 18.93B | 19.92B | 20.55B | 20.3B | |
Research & Development |
1.91B | 1.86B | 1.8B | 1.9B | 2B | |
Other SG&A |
16.89B | 17.06B | 18.12B | 18.65B | - | |
SGA Growth |
- | 0.67% | 5.27% | 3.16% | -1.23% | |
Other Operating Expense |
- | - | - | - | - | |
Unusual Expense |
1.07B | 9.05B | 699M | 1.14B | 104M | |
EBIT after Unusual Expense |
(1.07B) | 5.47B | 15.69B | 17.45B | 17.81B | |
Non Operating Income/Expense |
236M | 891M | 451M | 618M | 574M | |
Non-Operating Interest Income |
247M | 220M | 155M | 45M | 51M | |
Equity in Affiliates (Pretax) |
- | - | - | - | - | |
Interest Expense |
506M | 509M | 465M | 502M | 439M | |
Interest Expense Growth |
- | 0.59% | -8.64% | 7.96% | -12.55% | |
Gross Interest Expense |
506M | 509M | 465M | 502M | 439M | |
Interest Capitalized |
- | - | - | - | - | |
Pretax Income |
13.33B | 6.07B | 15.83B | 17.62B | 18B | |
Pretax Income Growth |
- | -54.46% | 160.90% | 11.25% | 2.16% | |
Pretax Margin |
- | - | - | - | 22.44% | NA |
Income Tax |
3.47B | 2.1B | 2.73B | 3.26B | 3.2B | |
Income Tax - Current Domestic |
4.18B | 1.26B | 1.56B | 1.99B | 2.27B | |
Income Tax - Current Foreign |
1.13B | 1.26B | 1.77B | 1.53B | 1.33B | |
Income Tax - Deferred Domestic |
(1.99B) | (296M) | 39M | (65M) | (320M) | |
Income Tax - Deferred Foreign |
145M | (115M) | (635M) | (193M) | (82M) | |
Income Tax Credits |
- | - | - | - | - | |
Equity in Affiliates |
- | - | - | - | - | |
Other After Tax Income (Expense) |
- | - | - | - | - | |
Consolidated Net Income |
9.86B | 3.97B | 13.1B | 14.35B | 14.79B | |
Minority Interest Expense |
111M | 69M | 76M | 46M | 51M | |
Net Income |
9.75B | 3.9B | 13.03B | 14.31B | 14.74B | |
Net Income Growth |
- | -60.03% | 234.28% | 9.82% | 3.05% | |
Net Margin Growth |
- | - | - | - | 18.38% | NA |
Extraordinaries & Discontinued Operations |
- | - | - | - | - | |
Extra Items & Gain/Loss Sale Of Assets |
- | - | - | - | - | |
Cumulative Effect - Accounting Chg |
- | - | - | - | - | |
Discontinued Operations |
- | - | - | - | - | |
Net Income After Extraordinaries |
9.75B | 3.9B | 13.03B | 14.31B | 14.74B | |
Preferred Dividends |
265M | 263M | 263M | 271M | 281M | |
Net Income Available to Common |
9.49B | 3.63B | 12.76B | 14.04B | 14.46B | |
EPS (Basic) |
3.75 | 1.45 | 5.13 | 5.69 | 6.00 | |
EPS (Basic) Growth |
- | -61.33% | 253.94% | 10.91% | 5.41% | |
Basic Shares Outstanding |
2.53B | 2.5B | 2.49B | 2.47B | 2.41B | |
EPS (Diluted) |
3.67 | 1.43 | 4.96 | 5.50 | 5.81 | |
EPS (Diluted) Growth |
- | -61.04% | 246.94% | 10.86% | 5.56% | |
Diluted Shares Outstanding |
2.66B | 2.54B | 2.63B | 2.6B | 2.54B | |
EBITDA |
17.25B | 17.34B | 19.41B | 21.33B | 20.72B | |
EBITDA Growth |
- | 0.48% | 11.93% | 9.90% | -2.85% | |
EBITDA Margin |
- | - | - | - | 25.84% | NA |